UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of undetected cases during the COVID-19 epidemic in Austria

BMC infectious diseases, 2021-01, Vol.21 (1), p.70-70, Article 70

2021

Volltextzugriff (PDF)

Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review

Epidemiology and infection, 2015-07, Vol.143 (9), p.1791-1802

2015

Volltextzugriff (PDF)

Cost-effectiveness of primary HPV screening for cervical cancer in Germany – a decision analysis

European journal of cancer (1990), 2011-07, Vol.47 (11), p.1633-1646

2011

Volltextzugriff (PDF)

Epidemiology and Clinical Features of Imported Dengue Fever in Europe: Sentinel Surveillance Data from TropNetEurop

Clinical infectious diseases, 2002-11, Vol.35 (9), p.1047-1052

2002

Volltextzugriff (PDF)

Malaria prophylaxis policy for travellers from Europe to the Indian Sub Continent

Malaria journal, 2006-02, Vol.5 (1), p.7-7, Article 7

2006

Volltextzugriff (PDF)

Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C

Journal of viral hepatitis, 2010-01, Vol.17 (1), p.34-50

2010

Volltextzugriff (PDF)

The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany

Value in health, 2013-11, Vol.16 (7), p.A574-A575

2013

Volltextzugriff (PDF)

The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening

Value in health, 2014-11, Vol.17 (7), p.A559-A559

2014

Volltextzugriff (PDF)

EE406 Colorectal Cancer Screening - Benefit-Harm and Cost-Effectiveness Analysis of Population-Wide Screening Strategies in Austria

Value in health, 2022-12, Vol.25 (12), p.S135-S135

2022

Volltextzugriff (PDF)

Benefit, risks and cost-effectiveness of screening for abdominal aortic aneurysm

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2010-07, Vol.182 (7), p.573

2010

Volltextzugriff (PDF)

IN2 Chronic Hepatitis C Treatment For Genotype 2 Or 3: COST-Effectiveness Analysis of Peg as First Line Treatment With the Brazilian Protocol

Value in health, 2011, Vol.14 (7), p.A540-A540

2011

Volltextzugriff (PDF)

PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

Value in health, 2011, Vol.14 (7), p.A424-A425

2011

Volltextzugriff (PDF)

122 HCV BURDEN IN EUROPE: IMPACT OF NATIONAL TREATMENT PRACTICES ON FUTURE HCV-RELATED MORBIDITY AND MORTALITY THROUGH A MODELING APPROACH

Journal of hepatology, 2011-03, Vol.54, p.S54-S54

2011

Volltextzugriff (PDF)

HPR171 COVID 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern?

Value in health, 2022-12, Vol.25 (12), p.S263-S263

2022

Volltextzugriff (PDF)

CO4 How Can the Long-Term Benefits and Harms of Screening Be Transparently Quantified and Contrasted for Informed Decision-Making? Colorectal Cancer Screening for Persons at Familial Risk (FARKOR)

Value in health, 2022-12, Vol.25 (12), p.S17-S17

2022

Volltextzugriff (PDF)

HTA170 Including Decision-Analytic Benefit-Harm Evaluation in HTA - Different Age Ranges and Screening Intervals in Breast Cancer Screening in Germany

Value in health, 2022-12, Vol.25 (12), p.S329-S329

2022

Volltextzugriff (PDF)

Imported leishmaniasis in Germany 2001-2004 : data of the SIMPID surveillance network

European journal of clinical microbiology & infectious diseases, 2005-07, Vol.24 (7), p.471-476

2005

Volltextzugriff (PDF)

P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study

Value in health, 2022-07, Vol.25 (7), p.S290-S290

2022

Volltextzugriff (PDF)

POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study

Value in health, 2022-01, Vol.25 (1), p.S121-S121

2022

Volltextzugriff (PDF)

Evaluation of a targeted COVID‐19 vaccination strategy for Austria–a decision-analytic modeling study

European journal of public health, 2021-10, Vol.31 (Supplement_3)

2021

Volltextzugriff (PDF)

EE458 Benefits, Costs and Cost Effectiveness of a Chronic Heart Failure Disease Management Program for Austria – a Decision-Analytic Modeling Study

Value in health, 2023-12, Vol.26 (12), p.S139

2023

Volltextzugriff (PDF)

EE131 Health-Economic Evaluation of Early Screening for Individuals Younger Than Age 50 with Familial Colorectal Cancer Risk Based on a Decision Analysis within the Farkor Study

Value in health, 2022-07, Vol.25 (7), p.S360

2022

Volltextzugriff (PDF)

PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four Continents

Value in health, 2011, Vol.14 (7), p.A355-A356

2011

Volltextzugriff (PDF)

OC-17 HCV burden in Europe: Impact of national treatment practices on future HCV-related morbidity and mortality through a modeling approach

Digestive and liver disease, 2011, Vol.43, p.S70-S70

2011

Volltextzugriff (PDF)

Epidemiological and clinical features of travel-associated cryptosporidiosis

Clinical microbiology and infection, 2006-09, Vol.12 (9), p.921-924

2006

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of undetected cases during the COVID-19 epidemic in Austria

Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review

Cost-effectiveness of primary HPV screening for cervical cancer in Germany – a decision analysis

Epidemiology and Clinical Features of Imported Dengue Fever in Europe: Sentinel Surveillance Data from TropNetEurop

Malaria prophylaxis policy for travellers from Europe to the Indian Sub Continent

Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C

The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany

The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening

EE406 Colorectal Cancer Screening - Benefit-Harm and Cost-Effectiveness Analysis of Population-Wide Screening Strategies in Austria

Benefit, risks and cost-effectiveness of screening for abdominal aortic aneurysm

IN2 Chronic Hepatitis C Treatment For Genotype 2 Or 3: COST-Effectiveness Analysis of Peg as First Line Treatment With the Brazilian Protocol

PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

122 HCV BURDEN IN EUROPE: IMPACT OF NATIONAL TREATMENT PRACTICES ON FUTURE HCV-RELATED MORBIDITY AND MORTALITY THROUGH A MODELING APPROACH

HPR171 COVID 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern?

CO4 How Can the Long-Term Benefits and Harms of Screening Be Transparently Quantified and Contrasted for Informed Decision-Making? Colorectal Cancer Screening for Persons at Familial Risk (FARKOR)

HTA170 Including Decision-Analytic Benefit-Harm Evaluation in HTA - Different Age Ranges and Screening Intervals in Breast Cancer Screening in Germany

Imported leishmaniasis in Germany 2001-2004 : data of the SIMPID surveillance network

P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study

POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study

Evaluation of a targeted COVID‐19 vaccination strategy for Austria–a decision-analytic modeling study

EE458 Benefits, Costs and Cost Effectiveness of a Chronic Heart Failure Disease Management Program for Austria – a Decision-Analytic Modeling Study

EE131 Health-Economic Evaluation of Early Screening for Individuals Younger Than Age 50 with Familial Colorectal Cancer Risk Based on a Decision Analysis within the Farkor Study

PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four Continents

OC-17 HCV burden in Europe: Impact of national treatment practices on future HCV-related morbidity and mortality through a modeling approach

Epidemiological and clinical features of travel-associated cryptosporidiosis

Suchergebnisse filtern